These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36286804)

  • 1. [Myocardial scintigraphy with
    Ansheles AA; Nasonova SN; Zhirov IV; Saidova MA; Stukalova OV; Tereshchenko SN; Sergienko VB
    Ter Arkh; 2022 May; 94(4):530-537. PubMed ID: 36286804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
    Takezaki M; Ishida Y; Morozumi T; Tani A; Sato H; Hori M; Kitabatake A; Kamada T; Kimura K; Kozuka T
    Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.
    Falk RH; Lee VW; Rubinow A; Hood WB; Cohen AS
    Am J Cardiol; 1983 Mar; 51(5):826-30. PubMed ID: 6299087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Negativity of myocardial scintigraphy with technetium-pyrophosphate in a case of primary cardiac amyloidosis].
    Volpi A; Cavalli A; Maggioni AP; Inglese E; Rovelli GE; Neri R; Salvi A
    G Ital Cardiol; 1985 Sep; 15(9):925-9. PubMed ID: 3002892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.
    Gertz MA; Brown ML; Hauser MF; Kyle RA
    Arch Intern Med; 1987 Jun; 147(6):1039-44. PubMed ID: 3036031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is technetium-99 m-pyrophosphate scintigraphy valuable in the diagnosis of cardiac amyloidosis?
    Hartmann A; Frenkel J; Hopf R; Baum RP; Hör G; Schneider M; Kaltenbach M
    Int J Card Imaging; 1990; 5(4):227-31. PubMed ID: 2172406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of technetium pyrophosphate scintigraphy in demonstrating cardiac amyloidosis in persons aged 85 years and older.
    Goldstein SA; Lindsay J; Chandeysson PL; Nolan NG
    Am J Cardiol; 1989 Mar; 63(11):752-3. PubMed ID: 2538049
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnostic significance of technetium-99m-pyrophosphate, technetium-99m-methylene diphosphonate and gallium-67-citrate scintigraphy in amyloid heart disease--a study with AL amyloidosis and familial amyloid polyneuropathy].
    Hongo M; Misawa T; Yamada H; Hirayama J; Okubo S; Fujii T; Kusama S; Ikeda S
    Nihon Naika Gakkai Zasshi; 1986 Jan; 75(1):1-8. PubMed ID: 3009667
    [No Abstract]   [Full Text] [Related]  

  • 10. Technetium 99m-pyrophosphate scintigraphy in amyloid cardiomyopathy.
    Ptacin MJ; Bamrah V; Duthie E
    Wis Med J; 1985 Mar; 84(3):25-7. PubMed ID: 2986368
    [No Abstract]   [Full Text] [Related]  

  • 11. Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis.
    Janssen S; Piers DA; van Rijswijk MH; Meijer S; Mandema E
    Eur J Nucl Med; 1990; 16(8-10):663-70. PubMed ID: 2166666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive diagnosis of cardiac amyloidosis by technetium-99m-pyrophosphate myocardial scintigraphy.
    Sobol SM; Brown JM; Bunker SR; Patel J; Lull RJ
    Am Heart J; 1982 Apr; 103(4 Pt 1):563-6. PubMed ID: 6278908
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac Amyloidosis Imaging, Part 3: Interpretation, Diagnosis, and Treatment.
    Jerome S; Farrell MB; Warren J; Embry-Dierson M; Schockling EJ
    J Nucl Med Technol; 2023 Jun; 51(2):102-116. PubMed ID: 37268322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cardio-focal and chest reconstruction of technetium-99m pyrophosphate scintigraphy for diagnosis of transthyretin cardiac amyloidosis: a quality assurance study.
    Akincioglu C; Murthi M; Romsa J; Warrington J; Malhotra S
    J Nucl Cardiol; 2023 Dec; 30(6):2607-2614. PubMed ID: 37012525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis.
    Wizenberg TA; Muz J; Sohn YH; Samlowski W; Weissler AM
    Am Heart J; 1982 Apr; 103(4 Pt 1):468-73. PubMed ID: 6278906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two autopsy cases of wild-type transthyretin cardiac amyloidosis who died 10 days after technetium-99m-pyrophosphate scintigraphy.
    Takahashi K; Morioka H; Sasaki D; Yamamura N; Kitazawa S; Ueda M; Sakaue T; Enomoto D; Uemura S; Okura T; Ikeda S
    J Nucl Cardiol; 2023 Oct; 30(5):2215-2221. PubMed ID: 36352088
    [No Abstract]   [Full Text] [Related]  

  • 17. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
    Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS
    JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Kumamoto criteria for prediction of
    Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
    J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative technetium pyrophosphate and cardiovascular magnetic resonance in patients with suspected cardiac amyloidosis.
    Roshankar G; White GC; Cadet S; Fine NM; Chan D; White JA; Jimenez-Zepeda V; Slomka PJ; Miller RJH
    J Nucl Cardiol; 2022 Oct; 29(5):2679-2690. PubMed ID: 34604925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In the thick of it: hereditary cardiac amyloidosis identified by
    Smiley D; Einstein AJ; Chan N; Mintz A; Santana DD; Shetty M; Sekulic M; Goldner K; Wall J; Helmke S; Maurer MS
    J Nucl Cardiol; 2023 Jun; 30(3):1258-1262. PubMed ID: 37138173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.